What does global increased expenditure on research and trials of autonomous vehicles mean for the legal landscape in Australia and how can you manage inherent risks? Watch this webinar to find out more.
A Legal Framework for Artificial Intelligence
Posted in Technology and innovation Blog post Artificial intelligence AI
IP Partner Maya Medeiros discusses the applications and legal definitions of artificial intelligence, and where law applies to particular AI processes or systems.
Artificial Intelligence and Separate Legal Personality
Posted in Artificial intelligence AI Technology and innovation Blog post
As artificial intelligence becomes more ubiquitous, the scope for economic loss or physical damage – on a B2B or B2C basis - inevitably grows too. James Russell and Paimon Abedi discuss the impact of AI.
BoE and FCA joint report on machine learning in UK Financial Services
Posted in AI Artificial intelligence Financial institutions Technology and innovation Blog post
Imogen Garner and Albert Weatherill discuss the joint report published by Bank of England and the FCA on machine learning in UK financial services.
AI as a solution for cybersecurity problems in M&A deals
Posted in AI Artificial intelligence Canada Technology and innovation Data protection Blog post
This blog post explores the immense potential of Artificial Intelligence as a solution for cybersecurity vulnerabilities in M&A deals.
CIIs – The Australian Full Court Encompass Decision
IP lawyers Harrison Ottaway and Helen Macpherson discuss the contentious topic of the patentability of computer implemented inventions (CII) in Australian patent law.
Deepfakes: Fake videos need real remedy
Posted in AI Artificial intelligence Technology and innovation Blog post Canada
Deepfakes appear genuine, with creators using AI and photos of nonconsenting people to make footage. IP partner Daniel Daniele discusses its malicious uses and legal advice for victims.
Vestager’s Digital Antitrust Blueprint
Posted in Blog post Antitrust and competition Regulation Ethics
Effects of Commissioner Vestager’s unprecedented nomination to a second term as Competition Commissioner and dual mandate as Executive Vice-President for a Europe fit for the Digital Age (Digital Commissioner).
AI and Drug Discovery, Part 3: Protecting the Value of Data in Collaborations
Posted in Blog post Technology and innovation Life sciences and healthcare Artificial intelligence AI
In Part 3, we highlight some of the legal issues surrounding the use of AI/ML in collaborative drug discovery and some solutions for addressing these issues.
AI and Drug Discovery, Part 2: In-Depth Look at the Mellody Project
Posted in Technology and innovation Life sciences and healthcare Artificial intelligence AI
Part 2 looks at an historic cross-competitor collaboration in the EU that is also leveraging blockchain technology to share large amounts of data to improve predictive models in drug discovery.